Searched for
BIOSIMILAR PERTUZUMAB
Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bidRating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's propos...08 Sep, 2026, 04.02 PM IST- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...08 Sep, 2026, 11.18 AM IST
- Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...08 Sep, 2026, 08.41 AM IST
- Biocon Biologics to introduce three new biosimilars for cancer treatmentBiocon Biologics will launch three new oncology biosimilars. These include Trastuzumab/Hyaluronidase, Nivolumab, and Pembrolizumab. The com...06 Jan, 2026, 07.41 PM IST
- Alkem launches breast cancer biosimilar in IndiaAlkem Laboratories has launched Pertuza, a biosimilar of pertuzumab, in India for treating HER2-positive breast cancer. This indigenously d...22 Sep, 2025, 08.03 PM IST
- Supreme Court asks Zydus Lifesciences to approach Delhi HC over ban on selling breast cancer drug SigrimaThe Supreme Court has instructed Zydus Lifesciences to approach the Delhi High Court. Zydus is seeking relief from an order that prevents t...18 Nov, 2024, 08.28 PM IST
- Delhi HC allows Zydus Lifesciences to sell breast cancer drug SigrimaThe Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations of it being si...15 Oct, 2024, 08.14 PM IST
- Zydus barred from selling cancer biosimilar, for nowThe Delhi High Court has temporarily barred Zydus Lifesciences from selling its breast cancer drug Sigrima, a biosimilar of Roche's Perjeta...10 Jul, 2024, 11.56 PM IST
- Stocks in news: JSW Infra, Stanley Lifestyles, SAMHI Hotels, Bank Of Baroda, IREDAIndicating that the company is still interested in the mega Tajpur deep sea port in West Bengal, JSW Infrastructure Ltd said that it remain...01 Jul, 2024, 06.45 AM IST
- Biocon Biologics may raise additional equity of $300 million in FY24 to pare debtBiocon Biologics plans to raise a further $300m by the end of FY24 in order to reduce its net debt, which peaked at $1.9bn in December 2022...25 May, 2023, 02.57 PM IST
- How Dr Reddy’s is rebooting its biosimilars playDr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.29 Sep, 2015, 02.51 AM IST
Load More
